Text Size

Autism in Adult Patients and the Effects on Caregivers

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by Sheba Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00367107
First received: August 21, 2006
Last updated: February 4, 2008
Last verified: February 2008
History of Changes
  Purpose

Background: The number of adults with autism is expected to rise significantly in the near future, due to two main reasons: First, a dramatic increase in the estimates of the prevalence of autism starting in the mid 1980s; Second, the clinical diagnosis of autism was first introduced during the 1950s, and those diagnosed with autism back then are only now entering middle age. Few studies, however, have focused on the outcomes of adult autistic individuals, and very little is known about the course of autism in adulthood and on the familial burden resulting from caring for an autistic adult. We therefore propose to study adult outcomes in autism, and to examine the influence of raising an autistic individual on the parents.

Working hypothesis and aims: The primary objectives of the study are:

  1. Determine clinical status and functioning of autistic adults.
  2. Study the influence of raising and caring for an individual with autism on the well-being of the parents.

Condition
Autism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Autism: Long Term Course and Impact

Resource links provided by NLM:

MedlinePlus related topics: Autism Caregivers
U.S. FDA Resources

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 240
Study Start Date: August 2008
Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   30 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

autisem

Criteria

Inclusion Criteria:

  • Autism or autism spectrum disorder
  • Understands the informed consent
  • Hebrew Speaker

Exclusion Criteria:

  • Severe acute or chronic illness
  • Substance abuse
  • In control subjects: Autism or autism spectrum disorder in subject or siblings
  • In control subjects: participating sibling
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00367107

Locations
Israel
Sheba Medical Center Not yet recruiting
Tel Hashomer, Israel
Principal Investigator: Gilad Gal, PhD            
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Raz Gros, MD Mental Health Epidemiology & Psychosocial Aspects of Illness, The Gertner Institute for Epidemiology and Health Policy Research
  More Information

No publications provided

Responsible Party: Raz Gross, Head, Mental Health Epidemiology, The Gertner Institute for Epidemiology
ClinicalTrials.gov Identifier: NCT00367107     History of Changes
Other Study ID Numbers: SHEBA-06-4169-RG-CTIL
Study First Received: August 21, 2006
Last Updated: February 4, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
Autism spectrum disorders
long-term outcomes
caregiver burden
birth cohort
nested case-control study

Additional relevant MeSH terms:
Autistic Disorder
Child Development Disorders, Pervasive
Mental Disorders Diagnosed in Childhood
Mental Disorders

ClinicalTrials.gov processed this record on May 22, 2013